PATENT CLAIM ANALYSIS

Application Number: 16031665
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "497000"]

Abstract:
A sterile pharmaceutical dosage form which comprises an ester capped lactide polymer, glycolide polymer or a lactide-glycolide copolymer hypercompressed with an active pharmaceutical ingredient wherein said sterile pharmaceutical dosage form has been sterilized with an electron beam and a method of preparing said sterile pharmaceutical dosage form.

Claim (Index 9):
A method of preparing a sterile hypercompressed pharmaceutical dosage form according to  claim 8  where the active pharmaceutical pharmaceutical ingredient is selected from the group consisting of steroids, non-steroidal anti-inflammatory drugs, antihistamines, antibiotics, mydriatics, beta-adrenergic antagonists anesthetics, alpha-2-beta adrenergic agonists, mast cell stabilizers, prostaglandin analogues, sympathomimetics, parasympathomimetics, antiproliferative agents, agents to reduce ocular angiogenesis and neovascularization, vasoconstrictors, anti-neoplastic agents, a polynucleotide, or a recombinant protein analog an angiogenic inhibitors and combinations thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.44118
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16032025', '12386853', '15981104', '13690647', '13408472']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7745084402741371
- 35 USC 102 Novelty (BERT): 0.5201379617886234
- Combined Prediction Score: 0.7490713924255858
- Mean Citation Score: 230.373748
- Max Citation Score: 334.43085
- Similarity Product: 300.0758930299669

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test